PENTAXIM ≥ 30 i.j./0.5 mL+ ≥ 40 i.j./0.5 mL+ ≥ 25 µg/0.5 mL+ 40 D'AG'U/0.5 mL+ 8 D'AG'U/0.5 mL+ 32 D'AG'U/0.5 mL+ 10 µg/0.5 mL p Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

pentaxim ≥ 30 i.j./0.5 ml+ ≥ 40 i.j./0.5 ml+ ≥ 25 µg/0.5 ml+ 40 d'ag'u/0.5 ml+ 8 d'ag'u/0.5 ml+ 32 d'ag'u/0.5 ml+ 10 µg/0.5 ml p

sanofi d.o.o. - пропорциональному protiv difterije, hemofilus utjecaj b, pertusisa, poliomijelitisa, tetanusa - prašak i suspenzija za suspenziju za injekciju - ≥ 30 i.j./0.5 ml+ ≥ 40 i.j./0.5 ml+ ≥ 25 µg/0.5 ml+ 40 d'ag'u/0.5 ml+ 8 d'ag'u/0.5 ml+ 32 d'ag'u/0.5 ml+ 10 µg/0.5 ml - 0,5 ml (1 doza ) pripremljene suspenzije sadrži: ≥ 30 i.j. prečišćeni toksoid difterije; ≥40 i.j prečišćeni toksoid tetanusa; 25 mcg antigen bordetella pertussis toksoid; 25 mcg antigen bordetella pertussis filamentozni hemaglutinin; 40 jedinica d antigena tip 1 poliomijelitis virus, inaktivisani; 8 jedinica d antig tip 2 poliomijelitis virus, inaktivisani; 32 jedinica d antigena tip 3 poliomijelitis virus, inaktivisani; 10 mcg polisaharid haemophilus influenzae tip b, konjugovani

Azacitidine Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

azacitidine mylan

mylan ireland limited - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.

Dasatinib Viatris 20 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dasatinib viatris 20 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - дазатиниб - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba

Jaglix 100 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jaglix 100 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 100 mg sitagliptina

Jaglix 25 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jaglix 25 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 25 mg sitagliptina

Jaglix 50 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jaglix 50 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina

Rivaroxaban Viatris (previously Rivaroxaban Mylan) Europska Unija - hrvatski - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Glerova 50 mg/1000 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

glerova 50 mg/1000 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin 15, irska - sitagliptinklorid hidrat metforminklorid - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 50 mg sitagliptina u obliku sitagliptinklorid hidrata i 1000 mg metforminklorida

Tikagrelor Pharmascience 60 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

tikagrelor pharmascience 60 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - tikagrelor - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 60 mg tikagrelora

Tikagrelor Pharmascience 90 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

tikagrelor pharmascience 90 mg filmom obložene tablete

pharmascience international limited, lampousas, 1, nicosia, cipar - tikagrelor - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 90 mg tikagrelora